Bellerophon Therapeutics Inc

Company Snapshot
184 Liberty Corner Road
Warren, NJ 07059
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 18
https://www.bellerophon.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
($26,276,000)
($20,161,000)
($22,384,000)
Net Income
($24,728,000)
($17,756,000)
($19,831,000)
2020
Gross Profit
Operating Income
($26,276,000)
Net Income
($24,728,000)
2021
Gross Profit
Operating Income
($20,161,000)
Net Income
($17,756,000)
2022
Gross Profit
Operating Income
($22,384,000)
Net Income
($19,831,000)
The above data on Bellerophon Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Peter Fernandes
Chief Executive Officer and Chief Regulatory, Safety and Quality Officer
$532,157
$153,400
$18,300
$703,857
Peter Fernandes
$703,857
Chief Executive Officer and Chief Regulatory, Safety and Quality Officer
Martin Dekker
Vice President Engineering and Manufacturing
$378,525
$120,360
$18,300
$517,185
Martin Dekker
$517,185
Vice President Engineering and Manufacturing
Parag Shah
Vice President Business Operations
$378,525
$120,360
$18,300
$517,185
Parag Shah
$517,185
Vice President Business Operations
Crispin Teufel
Independent Director
$52,500
$39,902
$0
$92,402
Crispin Teufel
$92,402
Independent Director
Scott Bruder
Independent Director
$45,000
$39,902
$0
$84,902
Scott Bruder
$84,902
Independent Director
Bellerophon Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us